Press releases

and Washington, D.C. (October 20, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced nine-month sub-population data from its TAXUS V clinical trial that further supports the...

and Washington, D.C. (October 19, 2005) -- Boston Scientific Corporation (NYSE: BSX) was recognized by physicians as a leader in the pursuit of evidence-based medicine through increased use of...

and Washington, D.C. (October 18, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced follow-up data supporting excellent long-term safety and efficacy from four of its TAXUS...

(October, 17, 2005) -- Boston Scientific Corporation (NYSE: BSX) today presented data from its BEACH clinical trial, which was designed to evaluate the benefits of carotid artery stenting (CAS) in...

, and Washington, D.C. (October 17, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced the combined results from the BLAZE and BLAZE II registries showing that its...

(October 14, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced financial results for its third quarter ended September 30, 2005 and provided revised revenue and earnings-per-share...

(October 13, 2005) -- Boston Scientific Corporation (NYSE: BSX) today introduced a new program that will offer participating medical centers in the United States a TAXUS® Express2™ stent system...

(October 13, 2005) -- Boston Scientific Corporation (NYSE: BSX) announced today that a Dutch appeals court yesterday overturned a lower court ruling and reinstated an injunction against the...

(October 10, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company

(October 7, 2005) -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the third quarter ended September 30, 2005 on Friday, October 14,...

(October 4, 2005)

(October 3, 2005) -- Boston Scientific Corporation (NYSE: BSX) announced today the grand opening of its new Maple Grove, Minnesota Research and Development facility, which includes several...

(September 19, 2005) -- Boston Scientific Corporation (NYSE: BSX) announced today the grand opening of its new Marlborough, Massachusetts office complex, which serves as the new headquarters for...

(September 16, 2005) -- Boston Scientific Corporation (NYSE: BSX) announced today that it has received clearance from the U.S. Food and Drug Administration (FDA) to market its Flextome™ Cutting...

(September 14, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that its Wayne, New Jersey manufacturing facility has been named one of the 10 best plants in North America by...

(September 13, 2005) -- Boston Scientific Corporation (NYSE: BSX) announced today that it has received CE Mark for the Precision™ Spinal Cord Stimulation (SCS) system, Europe

(September 13, 2005) -- Boston Scientific Corporation (NYSE: BSX) today welcomed an article in the Journal of the American Medical Association (JAMA) on the TAXUS V clinical trial that found the TAXUS

(September 8, 2005) -- Boston Scientific Corporation (NYSE: BSX) announced today that it has received CE Mark for its TAXUS® Liberté™ paclitaxel-eluting stent system, the world

(September 8, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that three of its drug-eluting stent clinical trials have been recognized as meeting the treatment guidelines of...

(September 7, 2005) -- Boston Scientific Corporation (NYSE: BSX) today commented on its third quarter performance. Speaking at the 2005 Thomas Weisel Partners Healthcare Conference in Boston,...

(September 6, 2005) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Bear Stearns 18th Annual Healthcare Conference, which is being held September 12 and 13 in New...

(September 1, 2005)

(September 1, 2005) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 2005 Thomas Weisel Partners Healthcare Conference, which is being held September 7 - 9 in...

(August 16, 2005)